Meds Apotek AB (STO:MEDS)
Sweden flag Sweden · Delayed Price · Currency is SEK
24.80
-0.60 (-2.36%)
At close: Jul 23, 2026

Meds Apotek AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
1,0931,018837.39659.97604.64
Revenue Growth
16.43%21.59%26.88%9.15%-
Gross Profit
307.21289.96240.16191.82153.45
Operating Income
4.65-2.41-8.16-49.12-106.57
Net Income
14.967.73-10.4-51.02-109.51
Earnings Per Share
0.800.43-0.60-3.05-7.14
EPS Growth
433.33%----

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
66.6645.1721.1750.5924.7
Total Debt
2.387.0524.0864.9138.8
Net Cash (Debt)
64.2838.12-2.92-14.33-14.1
Net Cash Growth
1769.03%----
Net Cash Per Share
3.442.14-0.17-0.86-0.92

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
13.56-21.2320.29-49.6-101.69
Capital Expenditures
-5.33-0.6-0.45-0.18-8.88
Free Cash Flow
8.23-21.8319.84-49.78-110.57
Free Cash Flow Growth
-55.74%----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
28.12%28.48%28.68%29.07%25.38%
Operating Margin
0.43%-0.24%-0.97%-7.44%-17.62%
Pretax Margin
0.43%-0.29%-1.33%-7.80%-17.82%
Profit Margin
1.37%0.76%-1.24%-7.73%-18.11%
FCF Margin
0.75%-2.14%2.37%-7.54%-18.29%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22
PE Ratio
30.80115.81---
Forward PE
14.8727.33---
PS Ratio
0.430.91---